Matthew Ringel, MD, Appointed Editor-in-Chief of Endocrine-Related Cancer
Nationally recognized for excellence in endocrinology
The Division of Endocrinology, Diabetes and Metabolism is committed to excellence in clinical care, the education of medical students, residents and fellows and to new discoveries to improve the care of patients with endocrine and endocrine-related disorders through laboratory and clinical research. Our division has a long history of outstanding performance in all of these areas and has recognized programs in diabetes, thyroid cancer and other thyroid disorders, adrenal and pituitary disorders and metabolic bone disease.
Our division by the numbers in FY20
24 faculty
#25 ranked by U.S. News & World Report
$32 million in NIH Funding
60 clinical trials
89 publications
Recent Highlights
Recent Innovations
Learn about more innovations in the Division of Endocrinology, Diabetes and Metabolism.
